Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of generic Rolexan and brand Clexane forms of enoxaparin
IRCT2016031910178N9Phase 4Completed
- Sponsor
- Ronak Pharmaceutical
- Start
- Apr 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of enoxaparin in deep vein thrombosis (DVT) (2 arms), sponsored by Ronak Pharmaceutical. Started Apr 2016; status: completed.
02
Drugs
enoxaparin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on IRCT2016031910178N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016031910178N9.